BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?
BMY jumps after strong Q4 2025 results as its growth portfolio drives beats, lifts sentiment and offsets generic pressure on legacy drugs.
Zacks·13h ago
More News
Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data
PFE shares fall even after Q4 earnings beat on COVID product declines and muted investor reaction to new obesity drug data.
Zacks·6d ago
Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings?
BMY heads into Q4 2025 earnings with strong Opdivo momentum, even as generic pressure continues to weigh on legacy drug sales.
Zacks·8d ago
Lingohr Asset Management GmbH Acquires 40,821 Shares of BioNTech SE Sponsored ADR $BNTX
Lingohr Asset Management GmbH boosted its position in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 598.4% during the 3rd quarter, according to its most recent 13F filing with...
MarketBeat·10d ago
Will BMY's Oncology Collaborations Drive Its Next Growth Phase?
BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.
Zacks·11d ago
Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings?
PFE heads into Q4 earnings with strong oncology and Vyndaqel demand, but IRA headwinds, COVID declines and falling estimates weigh on the outlook
Zacks·11d ago
BioNTech SE Sponsored ADR $BNTX Holdings Boosted by Lbp Am Sa
Lbp Am Sa raised its position in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 15.7% during the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·15d ago
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fifteen analysts that are presently covering the firm, MarketBeat reports. One...
MarketBeat·15d ago
Sector Gamma AS Has $2.74 Million Holdings in BioNTech SE Sponsored ADR $BNTX
Sector Gamma AS trimmed its holdings in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 26.0% during the third quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·16d ago
BioNTech (NASDAQ:BNTX) Earns Buy Rating from Berenberg Bank
Berenberg Bank restated a "buy" rating on shares of BioNTech in a research report on Friday...